Through a systematic evaluation of the relationship between common driver gene mutations in lung cancer and the expression level of ACACA, we observed frequent upregulation of ACACA expression in patients harboring TP53 mutations or EGFR mutations (Supplementary Figure 3). This evidence concerns the gene TP53 and lung carcinoma.